Clinicopathological Features , Outcomes and Prognostic Factors of High Risk Patients of Gestational Trophoblastic Neoplasia

NCT06900699 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2025-03-28

No results posted yet for this study

Summary

Aim of the Study This study aims to investigate the clinical and pathological features, treatment outcomes, and prognostic factors in high-risk patients with Gestational Trophoblastic Neoplasia (GTN).

Objectives:

* Identify common clinical and pathological features of high-risk GTN patients.
* Required surgical treatment as primary or subsequent line.
* Evaluate how well different treatments work and their side effects.
* Find factors that can help predict patient outcomes.
* Compare survival rates and relapse risks among patients.

Conditions

  • Gestational Trophoblastic Neoplasias (GTN)

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Neveen Adel Aness, master degree · Assiut University

  • Alaa EL-Din Mahmoud Ismail · Assiut University

  • Hisham Ahmed El-Sayed · Assiut University

  • Mostafa Mohammed Ahmed · Assiut University

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-30
Primary Completion
2026-04-30
Completion
2027-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06900699 on ClinicalTrials.gov